| Literature DB >> 24070420 |
Kate Lawrenson1, Maria Notaridou, Nathan Lee, Elizabeth Benjamin, Ian J Jacobs, Christopher Jones, Simon A Gayther.
Abstract
BACKGROUND: Fallopian tube secretory epithelial cells (FTSECs) have been implicated as a cell-of-origin for high-grade serous epithelial ovarian cancer. However, there are relatively few in vitro models of this tissue type available for use in studies of FTSEC biology and malignant transformation. In vitro three-dimensional (3D) cell culture models aim to recreate the architecture and geometry of tissues in vivo and restore the complex network of cell-cell/cell-matrix interactions that occur throughout the surface of the cell membrane.Entities:
Mesh:
Substances:
Year: 2013 PMID: 24070420 PMCID: PMC3849984 DOI: 10.1186/1471-2121-14-43
Source DB: PubMed Journal: BMC Cell Biol ISSN: 1471-2121 Impact factor: 4.241
Patient information
| 51 | NK | Mucinous cyst on the left ovary | Benign follicular and epithelial inclusion cysts. Benign serous cystadenofibroma. | Fallopian tubes normal | |
| 50 | NK | Benign fibrosis | Leiomyomas and folicular ovarian cysts | Mild chronic salpingitis in one tube but no evidence of malignancy | |
| 38 | Pre | Fibroid. Adenomyosis | Secretory endometrium and benign leiomyoma | Fallopian tubes normal | |
| 54 | Post | Complex hyperplasia with atypia | Autolysed endometrium. No evidence of invasive carcinoma. Benign leiomyomas. | Post-menopausal features present in both ovaries. Fallopian tubes normal. | |
| 65 | Post | Grade 2–3 endometrial cancer | Grade 2 endometrioid adenocarcinoma of the endometrium, with >50% myometrial invasion | Post-menopausal features present in both ovaries. Fallopian tubes normal. | |
| 60 | Post | History proven endometrial cancer | Grade 2 endometrioid adenocarcinoma of the endometrium | Fallopian tubes normal |
FTSEC cell lines were collected from patients aged between 38 and 65 years of age. For all patients, fallopian tube tissues were confirmed to be histologically normal. For the pre-menopausal patient the phase of the menstrual cycle was not known. NK = not known.
Figure 1Characterization of primary FTSEC cultures. (a) Primary FTSEC cultures maintain expression of markers expressed by fallopian tube secretory epithelia in vivo (arrowheads indicate secretory, non-ciliated cells), the FTSEC cultures express cytokeratins, CA125, basal laminin, vimentin and nuclear PAX8. 90-100% of cells stain positive for PAX8 suggesting fallopian tube ciliated epithelial cells do not proliferate in vitro. Green stain shows positive staining, nuclei are counterstained with DAPI (blue), except in the case of PAX8. (b) Growth curves. FTSECs have a limited in vitro lifespan, as is typical for primary normal cells. (c) Modal karyotypes for 5/6 primary FTSEC cultures were normal and female (46,XX). # Two cells or fewer showed unbalanced structural chromosomal rearrangements or numerical abnormalities.
Figure 2Histological analysis of 3D FTSEC spheroids. (a) Three dimensional spheroid cultures stained by hematoxylin and eosin. At (i) 15 days, the core of the spheroids contains abundant matrix material (*), covered by an epithelial cell monolayer (arrow) or cellular cap structure (arrowhead). (ii) After 40 days no viable cells remain within the core of the spheroids. A viable monolayer covers the surface of the spheroid (arrow), degenerate nuclear debris can be seen within the matrix core (arrowhead). (b) Electron microscopy of FTSEC spheroids. Features of epithelial cells in vivo are detected in 3D cultured FTSECs including (i) microvilli and cell-cell junction complexes including (ii,iii) tight junctions (white arrows and inset) and (iv) adherens junctions (white arrows and inset). Electron microscopy.
Figure 3Immunohistochemical staining of 2D and 3D cultured FTSECs and primary fallopian tube tissue. Immunohistochemical staining of p53 (clone Do7) and a proliferation marker, MIB1, shows high expression of both markers in 2D cultured cells but low expression in 3D FTSEC cultures (at day 15), and fallopian tube epithelia in vivo. Laminin and vimentin are expressed in 2D cultured cells, 3D cultured cells and in vivo. Expression of fibronectin and collagen I was lower in 2D cultured cells than 3D cultures and fallopian tube epithelia in fresh tissue specimens. Collagen IV is predominantly expressed in the basal lamina (arrow) and stroma of fallopian tubes but was expressed at high levels by 2D cultured cells. Expression of this marker was low/absent in 3D cultured cells. * Fibronectin, collagen I and collagen IV were also examined in FTSEC01, expression patterns were highly similar to data for FTSEC283 and FTSEC03. Expression of collagen IV was restricted to the basal lamina and stroma. None of the markers examined were differentially expressed by ciliated and secretory fallopian tube epithelial cells in vivo. As our cell isolates were predominantly PAX8 positive (Figure 1), we do not expect ciliated cells to be present in the FTSEC spheroid cultures. Brown stain denotes positive antigen detection, cells are counterstained with eosin (blue). Light microscopy. Scale bars = 100 μm.
Summary of immunohistochemical staining of FTSEC spheroids
| | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|
| AE1:AE3 | ++ | +/− | +++ | + | +++ | ++++ | ++++ | ++ | ++++ | ++++ |
| VIMENTIN | +++ | ++ | ++++ | +++ | ++++ | +++ | ++++ | +++ | ++++ | +++ |
| LAMININ | ++++ | ++++ | ++++ | ++++ | ++++ | ++++ | ++++ | ++++ | ++ | ++ |
| MUC-1 | ++ | +/− | + | - | + | +++ | ++ | - | ++++ | +++ |
| CA125 | + | - | + | - | +/− | ++ | ++ | - | +++ | +++ |
| PAX8 | + | - | ++ | +/− | +++ | +++ | ++ | +/− | +++ | ++ |
| TP53 (Do7) | +++ | +/− | +++ | + | ++ | + | +++ | +/− | + | +/− |
| MIB-1 (%) | 70% | <5% | 70% | <5% | 70% | <5% | 50% | <5% | <5% | <5% |
Immunohistochemistry was performed on five FTSEC cultures grown as 2D monolayers and as 3D spheroids, and compared to two fresh tissue specimens. Staining of pan-cytokeratin (AE1:AE3), mucin-1, CA125, PAX8 and E-Cadherin showed no significant changes in 2D versus 3D cultured cells. Laminin showed high levels of expression in all samples and expression along the basement membrane of fallopian tube epithelial cells in vivo. TP53 and MIB1 expression were high in 2D cultured cells, but low in 3D cultured cells and in vivo.
Figure 4Gene expression microarray analysis of 2D and 3D cultured FTSECs. Hierarchical clustering of transcriptomic profiles of the 100 genes showing the most significant changes in expression between three 2D and 3D cultured FTSEC primary lines. Three independent samples were prepared for each cell line and each culture condition, each sample represents an individual microarray, technical replicates are shown. Cell lines cluster according to culture conditions, not patient.
Analysis of gene ontology terms over-represented in 3D cultured cells
| Organelle fission | 11.106 | 61 | 321 | 2.00E-25 |
| Cell division | 8.987 | 50 | 266 | 7.74E-21 |
| Mitotic prometaphase | 2.872 | 30 | 83 | 2.50E-20 |
| Cell cycle process | 10.267 | 44 | 347 | 7.74E-14 |
| Cell cycle checkpoint | 2.962 | 23 | 87 | 3.72E-12 |
| Interphase | 11.522 | 41 | 333 | 4.02E-10 |
| Chromosome segregation | 2.835 | 20 | 84 | 1.14E-09 |
| Regulation of cell cycle process | 8.241 | 33 | 245 | 2.28E-09 |
| Cellular component organization or biogenesis | 104.766 | 163 | 3028 | 9.59E-09 |
| Cellular component organization at cellular level | 73.542 | 125 | 2225 | 1.97E-08 |
| DNA replication | 5.364 | 25 | 157 | 2.37E-08 |
| DNA strand elongation involved in DNA replication | 1.073 | 12 | 31 | 3.95E-08 |
| Mitotic cell cycle | 5.122 | 24 | 175 | 4.65E-08 |
| Negative regulation of cell cycle | 11.162 | 35 | 326 | 2.89E-07 |
| DNA metabolic process | 4.759 | 21 | 159 | 1.64E-06 |
| Microtubule anchoring | 0.830 | 9 | 24 | 8.20E-06 |
| Chromosome organization | 15.877 | 39 | 475 | 2.38E-05 |
| Cellular response to stress | 29.513 | 59 | 853 | 2.38E-05 |
| Mitosis | 4.269 | 18 | 137 | 3.02E-05 |
| Regulation of microtubule-based process | 2.284 | 13 | 66 | 3.94E-05 |
| Telomere maintenance via recombination | 0.796 | 8 | 23 | 6.95E-05 |
| DNA recombination | 3.716 | 16 | 111 | 8.96E-05 |
| Telomere maintenance via semi-conservative replication | 0.830 | 8 | 24 | 9.23E-05 |
| Double-strand break repair via homologous recombination | 1.419 | 10 | 41 | 9.61E-05 |
| DNA repair | 6.807 | 22 | 206 | 1.17E-04 |
| Mitotic spindle organization | 0.865 | 8 | 25 | 1.17E-04 |
| Microtubule-based process | 4.335 | 17 | 132 | 1.28E-04 |
| Chromosome localization | 0.657 | 7 | 19 | 1.74E-04 |
| Regulation of transcription involved in G1/S phase of mitotic cell cycle | 0.692 | 7 | 20 | 2.50E-04 |
| CenH3-containing nucleosome assembly at centromere | 0.727 | 7 | 21 | 3.41E-04 |
| DNA replication-independent nucleosome organization | 0.727 | 7 | 21 | 3.41E-04 |
| DNA packaging | 2.857 | 13 | 84 | 3.56E-04 |
| S phase of mitotic cell cycle | 4.325 | 16 | 125 | 4.55E-04 |
| Nucleotide-excision repair, DNA gap filling | 0.623 | 6 | 18 | 0.002 |
| ATP-dependent chromatin remodeling | 0.934 | 7 | 27 | 0.002 |
| Nucleosome assembly | 2.491 | 11 | 72 | 0.002 |
| Microtubule-based movement | 3.460 | 13 | 100 | 0.003 |
| G1/S transition of mitotic cell cycle | 4.693 | 15 | 138 | 0.004 |
| Anaphase-promoting complex-dependent proteasomal ubiquitin-dependent protein catabolic process | 2.733 | 11 | 79 | 0.005 |
| Transcription-coupled nucleotide-excision repair | 1.488 | 8 | 43 | 0.006 |
| Mitotic sister chromatid segregation | 0.510 | 5 | 15 | 0.006 |
| Establishment of organelle localization | 2.371 | 10 | 69 | 0.007 |
| Cellular component assembly | 34.876 | 57 | 1008 | 0.007 |
| Positive regulation of cell cycle cytokinesis | 0.311 | 4 | 9 | 0.009 |
| Mitotic metaphase | 0.138 | 3 | 4 | 0.009 |
| Spindle organization | 0.605 | 5 | 18 | 0.013 |
| Mitochondrial translation | 0.346 | 4 | 10 | 0.013 |
| DNA-dependent DNA replication initiation | 0.934 | 6 | 27 | 0.013 |
| G2/M transition DNA damage checkpoint | 0.934 | 6 | 27 | 0.013 |
| Maintenance of protein location | 2.630 | 10 | 76 | 0.013 |
| G2/M transition of mitotic cell cycle | 3.646 | 12 | 106 | 0.013 |
| Phosphatidylinositol-mediated signaling | 2.180 | 9 | 63 | 0.014 |
| Maintenance of location in cell | 2.664 | 10 | 77 | 0.014 |
| Spliceosomal snRNP assembly | 0.969 | 6 | 28 | 0.015 |
| Meiotic cell cycle | 3.737 | 12 | 108 | 0.015 |
| Microtubule depolymerization | 0.657 | 5 | 19 | 0.016 |
| Telomere organization | 1.799 | 8 | 52 | 0.016 |
| Mitotic chromosome condensation | 0.381 | 4 | 11 | 0.016 |
| Regulation of attachment of spindle microtubules to kinetochore | 0.173 | 3 | 5 | 0.016 |
| Spindle assembly | 1.001 | 6 | 29 | 0.016 |
| RNA splicing, via transesterification reactions | 6.747 | 17 | 195 | 0.017 |
| Cytoskeleton organization | 12.037 | 25 | 356 | 0.017 |
| Macromolecular complex subunit organization | 3.893 | 12 | 119 | 0.020 |
| Negative regulation of organelle organization | 4.048 | 12 | 117 | 0.028 |
| Attachment of spindle microtubules to kinetochore | 0.205 | 3 | 6 | 0.028 |
| Mitotic metaphase plate congression | 0.450 | 4 | 13 | 0.029 |
| Response to ionizing radiation | 3.010 | 10 | 87 | 0.030 |
| Regulation of cyclin-dependent protein kinase activity | 2.526 | 9 | 73 | 0.032 |
| Regulation of mitosis | 1.165 | 6 | 34 | 0.033 |
| RNA processing | 20.137 | 35 | 582 | 0.034 |
| Metaphase plate congression | 0.069 | 2 | 2 | 0.039 |
| Aspartate biosynthetic process | 0.069 | 2 | 2 | 0.039 |
| Glutamate catabolic process to aspartate | 0.069 | 2 | 2 | 0.039 |
| Glutamate catabolic process to 2-oxoglutarate | 0.069 | 2 | 2 | 0.039 |
| Regulation of hippo signaling cascade | 0.069 | 2 | 2 | 0.039 |
| Negative regulation of mitotic recombination | 0.069 | 2 | 2 | 0.039 |
| Deoxyribonucleotide biosynthetic process | 0.242 | 3 | 7 | 0.040 |
| Kinetochore assembly | 0.242 | 3 | 7 | 0.040 |
| Protein K6-linked ubiquitination | 0.242 | 3 | 7 | 0.040 |
| M phase of mitotic cell cycle | 0.239 | 3 | 8 | 0.041 |
| Positive regulation of transcription from RNA polymerase II promoter | 9.063 | 26 | 362 | 0.003 |
80 terms were over-represented in the genes that were underexpressed in 3D and 1 GO term was significantly over-represented in genes upregulated when FTSECs were transitioned to a 3D microenvironment. The majority of these terms were associated with cell cycle progression, mitosis and DNA replication.
Figure 5Validation of genes identified through expression microarray profiling of 2D and 3D cultured FTSECs. The most significantly changing genes were validated by TaqMan qPCR in independent 2D and 3D cultures of FTSEC03, as well as in two additional cell lines from different patients (FTSEC01 and FTSEC284). Genes downregulated in 3D cultured cells (a)MARCH4 and (b)DIAPH3 were significantly downregulated in all 3 cell lines tested with the exception. (c) A similar trend was observed for GINS4 although this did not reach statistical significance. Genes upregulated in 3D cultured cells (d)C11orf96, (e)OLFM2A and (f)LRRK2 were all upregulated in all 3 samples following a transition to a 3D microenvironment. * P > 0.05, ** P > 0.01, *** P > 0.001, two-tailed paired Student’s T-tests were used to compare 2D and 3D cultured cells for each cell line individually.
Figure 6FTSEC biomarker expression in 2D and 3D and cluster analysis comparing genome-wide transcriptomic profiles of 2D and 3D cultured FTSECs to follicular and luteal phase fallopian tube epithelium. (a) Expression of FTSEC biomarkers is typically higher in 3D than in 2D (i) oviductal glycoprotein 1, (ii) pregnanacy-associated plasma protein A and (iii) tissue factor pathway inhibitor 2. (b) Euclidean Pearson clustering analyses reveal that 2D cultured FTSECs cluster with follicular phase fallopian tube epithelium, whereas 3D cultured fallopian tube epithelial cells cluster with luteal phase tubal epithelium. Each point on the graph indicates an individual microarray profile, technical replicates of cultured cells are shown by colored circles, open circles denoting 2D cultured cells and closed circles denoting 3D cultured FTSECs. Black open circles indicate follicular phase fallopian tube epithelial samples, closed circles indicate luteal phase fallopian tube epithelium. Each point represents an individual patient. All patients from Georges et al. and Tone et al. [17,18] datasets are shown.